DarioHealth (DRIO) Stock Analysis & Winston Score
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a
Winston Score: 34/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (8/30)
- Growth: Mixed (5/20)
- Cash Flow: Weak (0/10)
- Stability: Mixed (4/10)
- Valuation: Good (5/10)
- Ownership: Good (10/15)
Key Facts
Price: $7.49
Market Cap: $55M
Sector: Healthcare
Industry: Medical - Specialties
Exchange: NASDAQ

